Novonix Statistics
Total Valuation
Novonix has a market cap or net worth of $227.39 million. The enterprise value is $218.06 million.
| Market Cap | 227.39M |
| Enterprise Value | 218.06M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Novonix has 122.25 million shares outstanding. The number of shares has increased by 1.02% in one year.
| Shares Outstanding | 122.25M |
| Shares Change (YoY) | +1.02% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.11% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 28.23 |
| Forward PS | n/a |
| PB Ratio | 1.24 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 27.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.37, with a Debt / Equity ratio of 0.38.
| Current Ratio | 11.37 |
| Quick Ratio | 10.49 |
| Debt / Equity | 0.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.22 |
Financial Efficiency
Return on equity (ROE) is -22.60% and return on invested capital (ROIC) is -19.77%.
| Return on Equity (ROE) | -22.60% |
| Return on Assets (ROA) | -17.10% |
| Return on Capital (ROIC) | -19.77% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | 1.38 |
Taxes
| Income Tax | -199,949 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -31.37% in the last 52 weeks. The beta is 1.52, so Novonix's price volatility has been higher than the market average.
| Beta (5Y) | 1.52 |
| 52-Week Price Change | -31.37% |
| 50-Day Moving Average | 2.10 |
| 200-Day Moving Average | 2.05 |
| Relative Strength Index (RSI) | 45.12 |
| Average Volume (20 Days) | 169,859 |
Short Selling Information
| Short Interest | 78,634 |
| Short Previous Month | 79,421 |
| Short % of Shares Out | 0.06% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.33 |
Income Statement
In the last 12 months, Novonix had revenue of $8.05 million and -$46.25 million in losses. Loss per share was -$0.00.
| Revenue | 8.05M |
| Gross Profit | 5.24M |
| Operating Income | -50.08M |
| Pretax Income | -46.45M |
| Net Income | -46.25M |
| EBITDA | -43.58M |
| EBIT | -43.58M |
| Loss Per Share | -$0.00 |
Balance Sheet
The company has $78.71 million in cash and $69.39 million in debt, giving a net cash position of $9.33 million or $0.08 per share.
| Cash & Cash Equivalents | 78.71M |
| Total Debt | 69.39M |
| Net Cash | 9.33M |
| Net Cash Per Share | $0.08 |
| Equity (Book Value) | 183.94M |
| Book Value Per Share | 1.50 |
| Working Capital | 81.31M |
Cash Flow
In the last 12 months, operating cash flow was -$36.23 million and capital expenditures -$19.20 million, giving a free cash flow of -$55.42 million.
| Operating Cash Flow | -36.23M |
| Capital Expenditures | -19.20M |
| Free Cash Flow | -55.42M |
| FCF Per Share | -$0.46 |
Margins
Gross margin is 65.02%, with operating and profit margins of -621.75% and -574.19%.
| Gross Margin | 65.02% |
| Operating Margin | -621.75% |
| Pretax Margin | -576.67% |
| Profit Margin | -574.19% |
| EBITDA Margin | -541.11% |
| EBIT Margin | -541.11% |
| FCF Margin | -688.11% |
Dividends & Yields
Novonix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.02% |
| Shareholder Yield | -1.02% |
| Earnings Yield | -20.34% |
| FCF Yield | -24.37% |
Analyst Forecast
The average price target for Novonix is $4.00, which is 115.05% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 115.05% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 77.41% |
| EPS Growth Forecast (5Y) | 172.86% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Novonix has an Altman Z-Score of 0.59 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.59 |
| Piotroski F-Score | 1 |